Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade.
about
Checkpoint Inhibitors and Their Application in Breast CancerRelevance of tumor-infiltrating lymphocytes in breast cancerAntagonists of PD-1 and PD-L1 in Cancer TreatmentStrategies to modulate the immune system in breast cancer: checkpoint inhibitors and beyondHow may targeted proteomics complement genomic data in breast cancer?The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.The immune microenvironment of breast ductal carcinoma in situ.Recent advances in the development of breast cancer vaccines.A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer.New Immunotherapy Strategies in Breast Cancer.Mammary gland involution as an immunotherapeutic target for postpartum breast cancer.Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis.Harnessing the immune system for the treatment of breast cancer.An atypical presentation of infiltrating ductal carcinoma.CTLA-4 positive breast cancer cells suppress dendritic cells maturation and function.Concomitant resistance and early-breast cancer: should we change treatment strategies?Emerging immunotherapy strategies in breast cancer.Immunotherapy for the treatment of breast cancer.Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunity.Breast Cancer Immunotherapy: Facts and Hopes.Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention.PD-L1 expression and the immune microenvironment in primary invasive lobular carcinomas of the breast.Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility.Immunotherapy for breast cancer: past, present, and future.Identification of a highly immunogenic mouse breast cancer sub cell line, 4T1-S.Targeting soluble proteins to exosomes using a ubiquitin tag.Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer.Advancing Immunotherapy in Metastatic Breast Cancer.Treating breast cancer with cell-based approaches: an overview.Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer.Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer.Computational vaccinology and the ICoVax 2012 workshop.Immunotherapy for Breast Cancer: What Are We Missing?Effect and safety of cytokine-induced killer (CIK) cell immunotherapy in patients with breast cancer: A meta-analysis.MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection.Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas.CTLA-4 checkpoint blockade in breast cancer, a case in point report.Cytotoxic T lymphocyte associated antigen 4 expression predicts poor prognosis in luminal B HER2-negative breast cancer.DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer.Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells
P2860
Q26745442-EADC850B-78EB-41BE-9D4E-5E65922D28D3Q26795598-9E7CD706-E1A5-4237-9E41-595AC3E38F65Q26796311-3184855B-4136-4201-AF7C-C847B1B62792Q28077815-138F04C1-A3AC-434F-B921-040EC7E8D7A3Q31140924-89871EF2-FB8F-46D8-8D1E-D3F24B0BA6F5Q33660069-25023784-C541-43E0-A88B-EF13E3AF222CQ33834968-AB40C799-04E3-47B0-801A-330D91E0477AQ34379303-8C1C6C17-3495-476F-86B0-2986914B54C5Q34412289-B083B2FE-3042-43FC-B4FD-21D2AE944B20Q34549227-C14AAA1E-30B0-4258-8076-540C14862CCDQ35186471-2124527E-1374-4EBC-B543-19FDC1FE0E5CQ35783412-A2BF4F68-DF5B-41AD-88D5-09E6F2A0CA69Q37476039-0EEF3FF5-D865-4148-B803-364CA5F9B20DQ37704939-ADB98FDD-D1C7-46E1-89FF-0EB1CBDA9207Q37706688-7D997F75-2DAC-46FB-99EF-40C4CD4A1941Q38171964-5C2F5D10-7982-44E6-96D0-6179EA415CDDQ38184650-0189F641-7997-44E4-8CD2-81FD9F8FEE29Q38353772-16377EF5-EBCC-4263-B077-07F2B1B09531Q38451287-34598236-FFAA-4EC1-B2EE-4E59159C609AQ38628198-084F165B-9CD0-43C0-A03D-1E57CC70B856Q38649483-D753997D-7565-4EBD-9E21-74E4068129B7Q38668389-F3812312-3727-41F4-958E-347844592284Q38734804-B4EF45A0-1DE8-4E9B-B301-587E5941F571Q38787696-151AD9AA-6390-4DFE-AE33-F5236350B717Q38795520-F5678A94-8A61-4FF5-90AA-E48E8A1F0501Q38819123-C6D54F51-CCD1-4A28-817B-ECBC71199A33Q39096364-DB9322B8-3270-4264-BB14-968C7FA34930Q39324161-DA5CE5BF-3DDC-4C9F-B05A-6A1EE1322558Q39448180-B1028DA2-27B7-4FEE-954F-D9B524184AA2Q41143084-414A1EC2-888F-418F-931C-D516E9B564CFQ42501422-1489730E-2A91-4588-B34A-B64053E59D5FQ43227656-7BBC4D63-3CD6-4B71-B116-AF4C83137586Q44668850-119A9A7C-AB44-4A03-B550-0DDCD688E13EQ47128387-93062F55-FB25-4BBC-ABF0-37E12F4146C3Q47560871-7E19BAFE-9A9F-4999-ABE1-B1E589AB9B7FQ52577907-DF052C75-1765-4AA8-B303-986882CFB052Q54888594-B422A32B-43A9-4DB3-9074-7F066E019F2DQ55296766-8C74E0A7-049F-4A96-B7F5-04F1791A7652Q55425717-D43E943E-9CD9-484B-8890-EDA687A9A06BQ57191726-6F3E9AB0-7191-4575-B632-BBDB1DA40465
P2860
Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Breast cancer immunobiology dr ...... nd immune checkpoint blockade.
@ast
Breast cancer immunobiology dr ...... nd immune checkpoint blockade.
@en
type
label
Breast cancer immunobiology dr ...... nd immune checkpoint blockade.
@ast
Breast cancer immunobiology dr ...... nd immune checkpoint blockade.
@en
prefLabel
Breast cancer immunobiology dr ...... nd immune checkpoint blockade.
@ast
Breast cancer immunobiology dr ...... nd immune checkpoint blockade.
@en
P2860
P356
P1476
Breast cancer immunobiology dr ...... nd immune checkpoint blockade.
@en
P2093
Leisha A Emens
P2860
P304
P356
10.1586/ERA.12.147
P577
2012-12-01T00:00:00Z